« Back
Home /
Vancomycin

Vancomycin

Item no.	HY-B0671-100mg
Manufacturer	MedChem Express
CASRN	1404-90-6
Amount	100 mg
Quantity options	100 mg 10 mM/1 mL 1 g 250 mg 25 mg 500 mg 50 mg
Category	Reagents & Chemicals Biochemicals
Type	Chemicals
Specific against	other
Purity	99.39
Citations	[1]Rybak MJ, et al. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S35-9.\|[2]Watanakunakorn C, et al. Mode of action and in-vitro activity of vancomycin. J Antimicrob Chemother. 1984 Dec;14 Suppl D:7-18.\|[3]Warren CA, et al. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother. 2013 Feb;57(2):689-96.\|[4]Juan He, et al. Vitamin C reduces vancomycin-related nephrotoxicity through the inhibition of oxidative stress, apoptosis, and inflammation in mice. Ann Transl Med. 2021 Aug; 9(16): 1319.\|[5]Ping Yu, et al. N-acetylcysteine Ameliorates Vancomycin-induced Nephrotoxicity by Inhibiting Oxidative Stress and Apoptosis in the in vivo and in vitro Models. Int J Med Sci. 2022; 19(4): 740–752. ACS Infect Dis. 2021 Aug 4.\|ACS Infect Dis. 2023 Nov 28.\|ACS Infect Dis. 2024 Apr 12;10(4):1327-1338.\|ACS Infect Dis. 2024 Jul 27.\|ACS Omega. 2023 Feb 2; 8 (6), 5415-5425.\|ACS Omega. 2023 Mar 6.\|ACS Omega. March 3, 2022.\|Adv Funct Mater. 2024 Jun 19.\|Am J Chin Med. 2024 Aug 21:1-28.\|AMB Express. 2024 Dec 24;14(1):141.\|Appl Microbiol Biotechnol. 2022 Apr;106(7):2689-2702.\|Aquaculture. 2021, 736248.\|Basic Clin Androl. 2025 Mar 7;35(1):9.\|Biochem Pharmacol. 2024 Oct 23:116593.\|bioRxiv. 2024 May 10.\|bioRxiv. 2025 February 13.\|Cancer Immunol Res. 2022 Dec 2;10(12):1542-1558.\|Cell Death Dis. 2021 Jun 7;12(6):582.\|Cell Metab. 2023 Sep 29:S1550-4131(23)00340-6.\|Cell Metab. 2024 Sep 28:S1550-4131(24)00366-8.\|Chemosphere. 2019 Jun;225:378-387. \|Curr Microbiol. 2023 May 31;80(7):230.\|Emerg Microbes Infect. 2022 Feb 22;1-34.\|Emerg Microbes Infect. 2024 Dec;13(1):2321981.\|Environ Health Perspect. 2022 Jun;130(6):67009.\|Front Microbiol. 2020 Jul 31;11:1720.\|Genome Biol. 2023 Apr 30;24(1):98.\|Gut Microbes. 2023 Dec;15(2):2249143.\|Heliyon. 2024 Jan 4.\|Infect Drug Resist. 2021 Dec 16;14:5449-5456.\|Int J Biol Macromol. 2024 Sep 19:135835.\|Int J Med Microbiol. 2020 Jan;69(1):120-131.\|Int J Med Sci. 2022 Apr 11;19(4):740-752.\|iScience. 2023 Mar.\|iScience. 2023 Oct 5.\|iScience. 5 January 2022, 103731.\|J Agric Food Chem. 2024 Apr 10.\|J Appl Microbiol. 2024 Jan 4:lxae001.\|J Cell Physiol. 2021 Dec 8.\|J Pharm Anal. 2023 Jun 16.\|Life Sci. 2020 Nov 15;261:118473.\|Microb Biotechnol. 2021 Mar 15.\|Microbiol Spectr. 2022 Mar 2;e0054121.\|Mol Immunol. 2022 Jul 6;149:94-106.\|Mol Pharm. 2022 Oct 21.\|Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct 1.\|Neural Regen Res. 2024 Sep 1;19(9):2081-2088.\|Pharmacol Res. 2024 May 21:205:107229.\|Phytomedicine. 2024 Nov 28:136:156297.\|Res Sq. 2024 Oct 02.\|Research Square Preprint. 2020 Jun.\|Research Square Preprint. 2024 Nov 13.\|Transl Res. 2022 Sep 5;S1931-5244(22)00198-0.\|Virulence. 2024 Dec;15(1):2367659.\|Virulence. 2024 Oct 10:2415952.\|Cell Rep. 2025 Feb 28;44(3):115356.\|Chem Eng J. 2024 Apr 15, 486 150125.\|Front Aging Neurosci. 2022 Jul 28;14:858130.\|NPJ Biofilms Microbiomes. 2024 Oct 28;10(1):111.\|Pol J Microbiol. 2023 Jun 14;72(2):199-208.\|Redox Biol. 2023 Oct 10, 102929.\|Small. 2021 Dec 19;e2107137.
Smiles	O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@H]2O)([H])C[C@@]2(N)C)[C@@H](O[C@H](CO)[C@H]1O)OC3=C(OC4=CC=C([C@H]([C@H]5NC([C@H](NC)CC(C)C)=O)O)C=C4Cl)C=C([C@](NC([C@@H](NC5=O)CC(N)=O)=O)([H])C(N[C@](C6=O)([H])C7=CC8=C(O)C=C7)=O)C=C3OC9=CC=C([C@H]([C@](C(N[C@@](C(O)=O)([H])C%10=C8C(O)=CC(O)=C%10)=O)([H])N6)O)C=C9Cl
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Shipping Condition	Room temperature
Available
Manufacturer - Type	Natural Products
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Antibiotic; Autophagy; Bacterial
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Molecular Weight	1449.25
Product Description	Vancomycin is an antibiotic for the treatment of bacterial infections.
Manufacturer - Research Area	Infection; Cancer
Solubility	DMSO: 100 mg/mL (ultrasonic)
Manufacturer - Pathway	Anti-infection; Autophagy
Isoform	Glycopeptide
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0671-100mg-safety-datasheet.pdf